7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Jurado S et al. | Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures. | 2010 | Osteoporos Int | pmid:19436932 |
Moran CS et al. | Association of PPARgamma allelic variation, osteoprotegerin and abdominal aortic aneurysm. | 2010 | Clin. Endocrinol. (Oxf) | pmid:19438902 |
Yilmaz Y et al. | Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease. | 2010 | Scand. J. Clin. Lab. Invest. | pmid:20942739 |
Zagura M et al. | Association of osteoprotegerin with aortic stiffness in patients with symptomatic peripheral artery disease and in healthy subjects. | 2010 | Am. J. Hypertens. | pmid:20224558 |
Jurado S et al. | Effect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts. | 2010 | J. Cell. Biochem. | pmid:20225238 |
Ma H et al. | Effects of diet-induced obesity and voluntary wheel running on bone properties in young male C57BL/6J mice. | 2010 | Calcif. Tissue Int. | pmid:20229059 |
Jono S et al. | Serum osteoprotegerin levels and long-term prognosis in subjects with stable coronary artery disease. | 2010 | J. Thromb. Haemost. | pmid:20230427 |
Kobayashi-Sakamoto M et al. | Osteoprotegerin induces cytoskeletal reorganization and activates FAK, Src, and ERK signaling in endothelial cells. | 2010 | Eur. J. Haematol. | pmid:20331738 |
Chen CH et al. | Soluble receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation. | 2010 | Clin. Rheumatol. | pmid:20690034 |
Lee HJ et al. | Heme oxygenase-1 protects human periodontal ligament cells against substance P-induced RANKL expression. | 2010 | J. Periodont. Res. | pmid:20337895 |
Røysland R et al. | Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial. | 2010 | Am. Heart J. | pmid:20691834 |
Noheria A et al. | Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension. | 2010 | Am. J. Hypertens. | pmid:20339356 |
Wiens M et al. | The role of biosilica in the osteoprotegerin/RANKL ratio in human osteoblast-like cells. | 2010 | Biomaterials | pmid:20673584 |
Mogi M and Kondo A | ELISA for RANKL-OPG complex in mouse sera. | 2010 | J Immunoassay Immunochem | pmid:20391022 |
Schramm HM | The role of the osteoimmune axis in the inflammation of the inner auditory ear and with regard to the putative anticarcinogenetic principle: part 2. | 2010 | Inflamm Allergy Drug Targets | pmid:20402646 |
Vik A et al. | Relation between serum osteoprotegerin and carotid intima media thickness in a general population - the Tromsø Study. | 2010 | J. Thromb. Haemost. | pmid:20738762 |
Bartold PM et al. | Mechanisms and control of pathologic bone loss in periodontitis. | 2010 | Periodontol. 2000 | pmid:20403105 |
Dalbeth N et al. | Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion. | 2010 | Arthritis Res. Ther. | pmid:20796300 |
Cody JJ et al. | Arming a replicating adenovirus with osteoprotegerin reduces the tumor burden in a murine model of osteolytic bone metastases of breast cancer. | 2010 | Cancer Gene Ther. | pmid:20798695 |
Fanourakis G et al. | Expression of receptor activator of NF-κB ligand and osteoprotegerin in peripheral giant cell granulomas of the jaws. | 2010 | J. Oral Pathol. Med. | pmid:20701665 |
Sanchez-Niño MD et al. | New paradigms in cell death in human diabetic nephropathy. | 2010 | Kidney Int. | pmid:20703212 |
Kauther MD et al. | Biochemical markers of particle induced osteolysis in C57BL/6 mice. | 2010 | Clin. Chem. Lab. Med. | pmid:20704528 |
Rooney T et al. | Synovial tissue rank ligand expression and radiographic progression in rheumatoid arthritis: observations from a proof-of-concept randomized clinical trial of cytokine blockade. | 2010 | Rheumatol. Int. | pmid:19847430 |
Vanella L et al. | HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage. | 2010 | Bone | pmid:19853072 |
Ochi H et al. | The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival. | 2010 | J. Orthop. Res. | pmid:19890995 |
Zhang Y et al. | Osteogenic properties of hydrophilic and hydrophobic titanium surfaces evaluated with osteoblast-like cells (MG63) in coculture with human umbilical vein endothelial cells (HUVEC). | 2010 | Dent Mater | pmid:20728208 |
Jensen JK et al. | Osteoprotegerin concentrations and prognosis in acute ischaemic stroke. | 2010 | J. Intern. Med. | pmid:19895657 |
Zupan J et al. | Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women. | 2010 | J. Steroid Biochem. Mol. Biol. | pmid:19896533 |
Walker CG et al. | Osteopontin is required for unloading-induced osteoclast recruitment and modulation of RANKL expression during tooth drift-associated bone remodeling, but not for super-eruption. | 2010 | Bone | pmid:20828639 |
Rianthavorn P et al. | Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium. | 2010 | Pediatr. Nephrol. | pmid:20676692 |
Le Heron L et al. | Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone. | 2010 | J. Cyst. Fibros. | pmid:20005786 |
Jules J et al. | Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis. | 2010 | Expert Opin. Ther. Targets | pmid:20678025 |
Shead EF et al. | Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis. | 2010 | J. Cyst. Fibros. | pmid:20006563 |
Fong JE et al. | Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase. | 2010 | J. Biol. Chem. | pmid:20679341 |
Kim M et al. | Td92, an outer membrane protein of Treponema denticola, induces osteoclastogenesis via prostaglandin E(2)-mediated RANKL/osteoprotegerin regulation. | 2010 | J. Periodont. Res. | pmid:20682013 |
Lossdörfer S et al. | Aging affects the phenotypic characteristics of human periodontal ligament cells and the cellular response to hormonal stimulation in vitro. | 2010 | J. Periodont. Res. | pmid:20682014 |
Ostrowski MC | A new role for OPG: putting RANKL in its place. | 2010 | J. Bone Miner. Res. | pmid:20684024 |
Secchiero P et al. | Baseline serum concentrations of TRAIL in early rheumatoid arthritis: relationship with response to disease-modifying antirheumatic drugs. | 2010 | J. Rheumatol. | pmid:20472926 |
Scheres N et al. | Gingival and periodontal ligament fibroblasts differ in their inflammatory response to viable Porphyromonas gingivalis. | 2010 | J. Periodont. Res. | pmid:19778323 |
Santos VR et al. | Receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in sites of chronic periodontitis of subjects with poorly and well-controlled type 2 diabetes. | 2010 | J. Periodontol. | pmid:20476881 |
Wu XY et al. | The relationship between the levels of gonadotropic hormones and OPG, leptin, TGF-beta1 and TGF-beta2 in Chinese adult women. | 2010 | Clin. Chim. Acta | pmid:20478283 |
Cawley NX et al. | Obese carboxypeptidase E knockout mice exhibit multiple defects in peptide hormone processing contributing to low bone mineral density. | 2010 | Am. J. Physiol. Endocrinol. Metab. | pmid:20460579 |
Jiang R et al. | High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer. | 2010 | Int. J. Cancer | pmid:19728335 |
Rhee EJ et al. | The relationship between Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) gene polymorphism and aortic calcification in Korean women. | 2010 | Endocr. J. | pmid:20431232 |
Wiwanitkit V | Osteoprotegerin and acute ischaemic stroke. | 2010 | J. Intern. Med. | pmid:20433585 |
Qian Y and Huang HZ | The role of RANKL and MMP-9 in the bone resorption caused by ameloblastoma. | 2010 | J. Oral Pathol. Med. | pmid:20412401 |
Qian H et al. | Activation of cannabinoid receptor CB2 regulates osteogenic and osteoclastogenic gene expression in human periodontal ligament cells. | 2010 | J. Periodont. Res. | pmid:20412420 |
Eagan TM et al. | Body composition and plasma levels of inflammatory biomarkers in COPD. | 2010 | Eur. Respir. J. | pmid:20413541 |
Lamoureux F et al. | Regulation of osteoprotegerin pro- or anti-tumoral activity by bone tumor microenvironment. | 2010 | Biochim. Biophys. Acta | pmid:19733222 |
Mine Y et al. | Impact of titanium ions on osteoblast-, osteoclast- and gingival epithelial-like cells. | 2010 | J Prosthodont Res | pmid:19733525 |
Martin-Bautista E et al. | Improvement of bone formation biomarkers after 1-year consumption with milk fortified with eicosapentaenoic acid, docosahexaenoic acid, oleic acid, and selected vitamins. | 2010 | Nutr Res | pmid:20579524 |
Tyrovola JB et al. | Relation of soluble RANKL and osteoprotegerin levels in blood and gingival crevicular fluid to the degree of root resorption after orthodontic tooth movement. | 2010 | J Oral Sci | pmid:20587957 |
McAllister SS and Weinberg RA | Tumor-host interactions: a far-reaching relationship. | 2010 | J. Clin. Oncol. | pmid:20644094 |
Gupta N et al. | IL-3 inhibits human osteoclastogenesis and bone resorption through downregulation of c-Fms and diverts the cells to dendritic cell lineage. | 2010 | J. Immunol. | pmid:20644169 |
Pedersen ER et al. | Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris. | 2010 | Atherosclerosis | pmid:20621297 |
Long L et al. | Dickkopf-1 as potential biomarker to evaluate bone erosion in systemic lupus erythematosus. | 2010 | J. Clin. Immunol. | pmid:20589421 |
Odiere MR et al. | Protein deficiency and nematode infection during pregnancy and lactation reduce maternal bone mineralization and neonatal linear growth in mice. | 2010 | J. Nutr. | pmid:20660285 |
Saito-Yabe M et al. | PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) results in decreased uptake into rats and human liver. | 2010 | J. Pharm. Pharmacol. | pmid:20663032 |
Pantsulaia I et al. | Association between radiographic hand osteoarthritis and RANKL, OPG and inflammatory markers. | 2010 | Osteoarthr. Cartil. | pmid:20633673 |
Byron CR et al. | In vitro expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in cultured equine articular cells. | 2010 | Am. J. Vet. Res. | pmid:20513175 |
Jilka RL et al. | Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms. | 2010 | J. Bone Miner. Res. | pmid:20533302 |
Paternoster L et al. | OPG and RANK polymorphisms are both associated with cortical bone mineral density: findings from a metaanalysis of the Avon longitudinal study of parents and children and gothenburg osteoporosis and obesity determinants cohorts. | 2010 | J. Clin. Endocrinol. Metab. | pmid:20534768 |
van Tuyl LH et al. | Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis. | 2010 | Ann. Rheum. Dis. | pmid:20525836 |
Zhang L et al. | Cell-based osteoprotegerin therapy for debris-induced aseptic prosthetic loosening on a murine model. | 2010 | Gene Ther. | pmid:20428210 |
Kim YG et al. | Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes. | 2010 | Arthritis Rheum. | pmid:20112365 |
Moreno-Rubio J et al. | Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis. | 2010 | Arthritis Rheum. | pmid:20112374 |
Wagner H | Bone diseases: Interferon regulatory factor-8 suppresses osteoclastogenesis. | 2010 | Nat Rev Rheumatol | pmid:20125173 |
Jiang XY et al. | Association of LPR5 polymorphism with bone mass density and cholesterol level in population of Chinese Han. | 2010 | Exp. Clin. Endocrinol. Diabetes | pmid:20146170 |
Stankovic KM et al. | Differences in gene expression between the otic capsule and other bones. | 2010 | Hear. Res. | pmid:20146935 |
Krause U et al. | Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. | 2010 | Proc. Natl. Acad. Sci. U.S.A. | pmid:20150512 |
Daoussis D et al. | Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis. | 2010 | Semin. Arthritis Rheum. | pmid:19095294 |
Makihira S et al. | Immobilized-OPG-Fc on a titanium surface inhibits RANKL-dependent osteoclast differentiation in vitro. | 2010 | J Mater Sci Mater Med | pmid:19834789 |
Kadoglou NP et al. | Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis. | 2010 | Eur J Vasc Endovasc Surg | pmid:20004120 |
Secchiero P et al. | An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction. | 2010 | Atherosclerosis | pmid:20015493 |
Pal SN et al. | Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification. | 2010 | Atherosclerosis | pmid:20004897 |
Rachner TD et al. | Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells. | 2010 | Cancer Lett. | pmid:19577359 |
Lee JE et al. | Impact of ENPP1 and MMP3 gene polymorphisms on aortic calcification in patients with type 2 diabetes in a Korean population. | 2010 | Diabetes Res. Clin. Pract. | pmid:20092902 |
Flyvbjerg A | Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily. | 2010 | Nat Rev Endocrinol | pmid:20098449 |
Wutzl A et al. | Bone morphogenetic proteins 2, 5, and 6 in combination stimulate osteoblasts but not osteoclasts in vitro. | 2010 | J. Orthop. Res. | pmid:20872578 |
Scudla V et al. | The importance of serum levels of selected biological parameters in the diagnosis, staging and prognosis of multiple myeloma. | 2010 | Neoplasma | pmid:20099972 |
Wang J and Stern PH | Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα(12) or constitutively active RhoA. | 2010 | J. Cell. Biochem. | pmid:20872746 |
Borsje MA et al. | Comparison of low-intensity pulsed ultrasound and pulsed electromagnetic field treatments on OPG and RANKL expression in human osteoblast-like cells. | 2010 | Angle Orthod | pmid:20050743 |
Ruiz-Gaspà S et al. | Lithocholic acid downregulates vitamin D effects in human osteoblasts. | 2010 | Eur. J. Clin. Invest. | pmid:20055894 |
Kochetkova EA et al. | [Osteoprotegerin and bone mineral density in patients with chronic obstructive pulmonary disease]. | 2010 | Ter. Arkh. | pmid:20873238 |
Sypniewska G et al. | Does serum osteoprotegerin level relate to fragility fracture in elderly women with low vitamin D status? | 2010 | Med. Sci. Monit. | pmid:20110921 |
Elias LS et al. | Markers of bone remodeling in neoplastic and bone-related lesions. | 2010 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:20955951 |
Nozaki K et al. | Effect of cyclic mechanical loading on osteoclast recruitment in periodontal tissue. | 2010 | J. Periodont. Res. | pmid:19602121 |
Subramaniam M et al. | TGFbeta inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts. | 2010 | Biochem. Biophys. Res. Commun. | pmid:20059964 |
O'Sullivan EP et al. | Osteoprotegerin is higher in peripheral arterial disease regardless of glycaemic status. | 2010 | Thromb. Res. | pmid:20932553 |
Corallini F et al. | TNF-alpha modulates the migratory response of mesenchymal stem cells to TRAIL. | 2010 | Cell. Mol. Life Sci. | pmid:20063037 |
Norazlina M et al. | Effects of vitamin E on receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) in rats treated with nicotine. | 2010 | Med. J. Malaysia | pmid:21265240 |
Tan YY et al. | Effects of vascular endothelial growth factor (VEGF) on MC3T3-E1. | 2010 | Orthod Craniofac Res | pmid:21040465 |
Gallo J et al. | [Synovial fluid from aseptically failed total hip or knee arthroplasty is not toxic to osteoblasts]. | 2010 | Acta Chir Orthop Traumatol Cech | pmid:21040654 |
Salah H et al. | The clinical significance of OPG/sRANKL ratio in thalassemia patients suffering from osteopenia or osteoporosis in Egyptian patients. | 2010 | Immunol. Invest. | pmid:20718662 |
Lee YH et al. | Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis. | 2010 | Mol. Biol. Rep. | pmid:19642016 |
Hesse E et al. | Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. | 2010 | J. Cell Biol. | pmid:21173110 |
Eagan TM et al. | Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. | 2010 | Eur. Respir. J. | pmid:19643942 |
Roato I et al. | Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase. | 2010 | PLoS ONE | pmid:21152388 |
Kenanidis EI et al. | Serum levels of bone turnover markers following total joint arthroplasty. | 2010 | J Orthop Surg (Hong Kong) | pmid:21187538 |
Wang X et al. | [Association of serum follicle stimulating hormone with osteoprotegerin, leptin, TGF-β1, and TGF-β2 in women]. | 2010 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | pmid:21200095 |